Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-09-01
|
| Series: | JAAD International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S266632872200058X |
| _version_ | 1811243393505820672 |
|---|---|
| author | Ronald Vender, MD Irina Turchin, MD Perla Lansang, MD Vimal H. Prajapati, MD Mark Legault, PhD Maxime Barakat, MD, PhD, MBA Jensen Yeung, MD |
| author_facet | Ronald Vender, MD Irina Turchin, MD Perla Lansang, MD Vimal H. Prajapati, MD Mark Legault, PhD Maxime Barakat, MD, PhD, MBA Jensen Yeung, MD |
| author_sort | Ronald Vender, MD |
| collection | DOAJ |
| first_indexed | 2024-04-12T14:06:37Z |
| format | Article |
| id | doaj.art-a53ddb810c5f4625922358a67799b58b |
| institution | Directory Open Access Journal |
| issn | 2666-3287 |
| language | English |
| last_indexed | 2024-04-12T14:06:37Z |
| publishDate | 2022-09-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD International |
| spelling | doaj.art-a53ddb810c5f4625922358a67799b58b2022-12-22T03:30:03ZengElsevierJAAD International2666-32872022-09-0186063Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart reviewRonald Vender, MD0Irina Turchin, MD1Perla Lansang, MD2Vimal H. Prajapati, MD3Mark Legault, PhD4Maxime Barakat, MD, PhD, MBA5Jensen Yeung, MD6Department of Medicine, Division of Dermatology, McMaster University, Hamilton, Ontario, Canada; Dermatrials Research Inc, Hamilton, Ontario, Canada; Correspondence to: Ronald Vender, MD, Dermatrials Research Inc, 707-25 Charlton Ave East, Hamilton, Ontario, Canada L8N 1Y2Brunswick Dermatology Centre, Fredericton, New Brunswick, Canada; Dalhousie University, Halifax, Nova Scotia, Canada; Probity Medical Research, Waterloo, Ontario, CanadaDivision of Dermatology, Women’s College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada; The Hospital for Sick Children, Toronto, Ontario, CanadaDivision of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, CanadaBausch Health Canada Inc, Laval, Quebec, CanadaBausch Health Canada Inc, Laval, Quebec, CanadaDivision of Dermatology, Women’s College Hospital, Toronto, Ontario, Canada; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canadahttp://www.sciencedirect.com/science/article/pii/S266632872200058Xbiologiccorticosteroidfixed combinationplaque psoriasisreal-worldretinoid |
| spellingShingle | Ronald Vender, MD Irina Turchin, MD Perla Lansang, MD Vimal H. Prajapati, MD Mark Legault, PhD Maxime Barakat, MD, PhD, MBA Jensen Yeung, MD Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review JAAD International biologic corticosteroid fixed combination plaque psoriasis real-world retinoid |
| title | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_full | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_fullStr | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_full_unstemmed | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_short | Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review |
| title_sort | real world treatment outcomes with halobetasol propionate 0 01 tazarotene 0 045 lotion in patients with mild to moderate plaque psoriasis a canadian multicenter retrospective chart review |
| topic | biologic corticosteroid fixed combination plaque psoriasis real-world retinoid |
| url | http://www.sciencedirect.com/science/article/pii/S266632872200058X |
| work_keys_str_mv | AT ronaldvendermd realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT irinaturchinmd realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT perlalansangmd realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT vimalhprajapatimd realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT marklegaultphd realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT maximebarakatmdphdmba realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview AT jensenyeungmd realworldtreatmentoutcomeswithhalobetasolpropionate001tazarotene0045lotioninpatientswithmildtomoderateplaquepsoriasisacanadianmulticenterretrospectivechartreview |